Bnp Paribas Investment Partners »

Aeglea Biotherapeutics shares owned by Bnp Paribas Investment Partners

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Bnp Paribas Investment Partners from 13F filings

Historical chart of Bnp Paribas Investment Partners investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Bnp Paribas Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Bnp Paribas Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.0k 335 17.91
2025-06-30 $6.0k 377 15.92